National Eating Disorders Association's Parent Toolkit
National Eating Disorders Association's Parent Toolkit
National Eating Disorders Association's Parent Toolkit
TOOLKIT
Table of Contents
I.
II.
III.
IV.
27
30
36
37
40
Insurance Issues........................................................................................ 43
Understanding Insurance Issues for Eating Disorders Treatment
Obtaining Insurance Benefits for Higher Levels of Care
Common Reasons for Denying Further Care
Steps to Take When Determining Coverage Allowances
Strategies for Providers for Fighting Insurance Denial
How to Manage an Appeals Process
Sample Letters to Use with Insurance Companies
Other Steps for Loved Ones
VI.
17
18
20
21
22
23
24
Treatment Information............................................................................. 26
Level of Care Guidelines for Patients
Finding Treatment for Your Loved Ones Eating Disorder
Questions to Ask a Treatment Provider Privately
Selecting a Treatment Center for Your Loved One
Treatment Glossary
V.
6
10
11
12
14
44
47
48
49
50
52
53
63
65
67
69
72
74
Page |2
Page |3
Page |4
About Eating
Disorders
Page |5
Page |6
Page |7
Page |8
Page |9
Perfectionism
Anxiety
Depression
Difficulties regulating emotion
Obsessive-compulsive behaviors
Rigid thinking style (only one right way to do
things, etc.)
Page |10
Individuals with eating disorders may be at risk for co-occurring conditions such as mood and anxiety disorders,
substance abuse (alcohol, marijuana, cocaine, heroin, methamphetamines, etc.), self-harm (cutting, etc.) and
suicidal thoughts and behaviors.
Page |11
Page |12
Page |13
Population-Wide Statistics
NEDA has gathered data on the prevalence of eating
disorders from the US, UK, and Europe to get a
better idea of exactly how common eating disorders
are. Older data from other countries that use more
strict definitions of anorexia and bulimia give lower
prevalence estimates:
In a study of 31,406 Swedish twins born from
1935-1958, 1.2% of the women had strictly
defined anorexia nervosa during their lifetime,
which increased to 2.4% when a looser
definition of anorexia was used (Bulik et al.,
2006).
For twins born between 1975 and 1979 in
Finland, 2.2-4.2% of women (Keski-Rahkonen
et al., 2007) and 0.24% of men (Raevuori et al.,
2009) had experienced anorexia during their
lifetime.
At any given point in time between 0.3-0.4%
of young women and 0.1% of young men will
suffer from anorexia nervosa, 1.0% of young
women and 0.1% of young men will suffer from
bulimia, with similar rates for binge eating
disorder (Hoek & van Hoeken, 2003).
Several more recent studies in the US have used
broader definitions of eating disorders that more
accurately reflect the range of disorders that occur,
resulting in a higher prevalence of eating disorders.
A 2007 study asked 9,282 English-speaking
Americans about a variety of mental health
conditions, including eating disorders. The
results, published in Biological Psychiatry,
found that:
Page |14
References:
Bulik CM, Sullivan PF, Tozzi F, Furberg H, Lichtenstein P, and
Pedersen NL. (2006). Prevalence, heritability, and prospective
risk factors for anorexia nervosa. Archives of General
Psychiatry, 63(3):305-12. doi:10.1001/archpsyc.63.3.305.
References (continued):
Favaro A, Caregaro L, Tenconi E, Bosello R, and Santonastaso
P. (2009). Time trends in age at onset of anorexia nervosa and
bulimia nervosa. Journal of Clinical Psychiatry, 70(12):1715-21.
doi: 10.4088/JCP.09m05176blu.
Hart LM, Granillo MT, Jorm AF, and Paxton SJ. (2011). Unmet
need for treatment in the eating disorders: a systematic
review of eating disorder specific treatment seeking among
community cases. Clinical Psychology Reviews, 31(5):727-35.
doi: 10.1016/j.cpr.2011.03.004.
Hoek HW and van Hoeken D. (2003). Review of the prevalence
and incidence of eating disorders. International Journal of
Eating Disorders, 34(4):383-96. doi: 10.1002/eat.10222.
Hudson JI, Hiripi E, Pope HG Jr, and Kessler RC. (2007). The
prevalence and correlates of eating disorders in the National
Comorbidity Survey Replication. Biological Psychiatry,
61(3):348-58. doi:10.1016/j.biopsych.2006.03.040.
Keski-Rahkonen A, Hoek HW, Susser ES, Linna MS, Sihvola
E, Raevuori A, , and Rissanen A. (2007). Epidemiology and
course of anorexia nervosa in the community. American
Journal of Psychiatry, 164(8):1259-65. doi: 10.1176/appi.
ajp.2007.06081388.
Lucas AR, Crowson CS, OFallon WM, Melton LJ 3rd. (1999).
The ups and downs of anorexia nervosa. International Journal
of Eating Disorders, 26(4):397-405. DOI: 10.1002/(SICI)1098108X(199912)26:4<397::AID-EAT5>3.0.CO;2-0.
Micali N, Hagberg KW, Petersen I, and Treasure JL. (2013). The
incidence of eating disorders in the UK in 20002009: findings
from the General Practice Research Database. BMJ Open, 3(5):
e002646. doi: 10.1136/bmjopen-2013-002646.
Raevuori A, Hoek HW, Susser E, Kaprio J, Rissanen A, and
Keski-Rahkonen A. (2009). Epidemiology of anorexia nervosa
in men: a nationwide study of Finnish twins. PLoS ONE, doi:
10.1371/journal.pone.0004402.
Smink FR, van Hoeken D, and Hoek HW. (2012). Epidemiology
of eating disorders: incidence, prevalence and mortality
rates. Current Psychiatry Reports, 14(4):406-14. doi: 10.1007/
s11920-012-0282-y.
Stice E & Bohon C. (2012). Eating Disorders. In Child and
Adolescent Psychopathology, 2nd Edition, Theodore
Beauchaine & Stephen Linshaw, eds. New York: Wiley.
Stice E, Marti CN, Shaw H, and Jaconis M. (2010). An 8-year
longitudinal study of the natural history of threshold,
subthreshold, and partial eating disorders from a community
sample of adolescents. Journal of Abnormal Psychology,
118(3):587-97. doi: 10.1037/a0016481.
van Son GE, van Hoeken D, Bartelds AI, van Furth EF, and Hoek
HW. (2012). Time trends in the incidence of eating disorders:
a primary care study in the Netherlands. International Journal
of Eating Disorders, 39(7):565-9. doi: 10.1002/eat.20316.
Page |15
Supporting a
Loved One
Page |16
Page |17
Page |18
Page |19
Patient Assessment
Patient history, including screening questions
about eating patterns
Determination of medical, nutritional,
psychological and social functioning (if
possible, an eating disorder expert should
assess the mental health of your child)
Attitudes towards eating, exercise, and
appearance
Family history of eating disorder or other
psychiatric disorder, including alcohol and
substance use disorders
Family history of obesity
Assessment of other mental health
conditions, such as depression and anxiety
Laboratory Testing
Complete Blood Count (CBC) with differential
urinalysis
Complete Metabolic Profile: sodium, chloride,
potassium, glucose, blood urea nitrogen
Creatinine, total protein, albumin, globulin,
calcium, carbon dioxide, aspartate transami
nase (AST), alkaline phosphatase (ALP), total
bilirubin
Serum magnesium, phosphate
Thyroid screen (T3, T4, TSH)
Electrocardiogram (ECG)
Special Circumstances
If uncertain of diagnosis
Erythrocyte sedimentation rate
Radiographic studies (computed tomography
or magnetic resonance imaging of the brain or
upper/lower gastrointestinal system)
If patient has been without her menstrual period for six
or more months
Urine pregnancy, luteinizing and folliclestimulating hormone, and prolactin tests
Forindividuals with persistent low weight, especially
females who sustain amenorrhea, a work-up should
include a Dual Energy X-ray Absorptiometry (DEXA) to
assess bone mineral density.
Medical Exam
Physical examination including height,
weight, body mass index (BMI), growth chart
assessment for children and adolescents,
cardiovascular and peripheral vascular
function, skin health, hair loss, evidence of
self-injurious behaviors
Measurement of body temperature and pulse
Orthostatic blood pressure
Laboratory tests (see below)
Dental exam if self-induced vomiting is known
or suspected
Establishment of diagnosis and recommenda
tions for appropriate level of care
Page |20
Page |21
Even if you dont feel the discussion was well-received or that you got through to your loved one, dont despair.
You shared your concern and let them know that you care and you are there for them. You may also have planted
a seed that they should seek help. The seed may not take root immediately, but over time, the concern of friends
and family can help move an individual towards recovery.
Note: If you suspect a medical or psychiatric emergency, such as threats of suicide or medical complications
from eating disorder behaviors (such as fainting, heart arrhythmias, or seizures), seek medical attention or call
911 immediately.
Page |22
recommend keeping the discussions brief and matterof-fact, while also giving the child a chance to express
his/her emotions and concerns about their family
member or friend.
Page |23
Guardianship
Seeking medical guardianship gives you the legal
authority to make decisions about a persons physical
and psychological care. It doesnt allow you to sign an
adult into a treatment program, but it does allow you
to be closely involved in the decision-making process.
To be granted, a judge must decide that a person isnt
capable of making these decisions on his or her own.
To obtain guardianship, you will need to seek a court
order. As laws, definitions, and regulations vary by
state, contact a family law attorney in your state for
more guidance.
Conservatorship
Conservatorship gives you the authority to manage
another persons finances. It can be useful in eating
disorders to reduce access to funds that are fueling
the disorder and allowing a seriously ill individual to go
untreated. There may also be other circumstances in
which conservatorship is warranted. To be granted, a
judge must decide that a person isnt capable of making
these decisions on his or her own.
To obtain conservatorship, you will need to seek a
court order. As laws, definitions, and regulations vary
by state, contact a family law attorney in your state for
more guidance.
Note: both conservatorship and guardianship are
governed under state law, and only effective in the
particular state where it is granted. If your loved one
seeks care in a different state, the guardianship or
conservatorship doesnt automatically transfer, and
you may need to seek additional legal advice and
court orders in this situation.
Page |24
Page |25
Treatment
Information
Page |26
American Psychiatric Association Level of Care Guidelines for Patients with Eating Disorders
Level One:
Outpatient
Medical Status
Level Two:
Intensive
Outpatient
Level Three:
Level Four:
Partial
Residential
Hospitalization Treatment
(Full-day
Outpatient Care)
Medically stable
to the extent that
intravenous fluids,
nasogastric tube
feedings, or multiple
daily laboratory
tests are not
needed
For adults:
Heart rate <40 bpm;
blood pressure
<90/60 mmHg;
glucose <60 mg/dl;
potassium <3 mEq/L;
electrolyte imbalance;
temperature <97.0F;
dehydration; liver,
kidney, or cardiac
compromise requiring
acute treatment;
poorly controlled
diabetes
For children and
adolescents:
Heart rate near 40
bpm; orthostatic blood
pressure changes
(>20 bpm increase
in heart rate or >10
mmHg to 20 mmHg
drop); blood pressure
<80/50 mmHg; low
potassium, phosphate,
or magnesium levels
Page |27
Level One:
Outpatient
Level Two:
Intensive
Outpatient
Level Three:
Level Four:
Partial
Residential
Hospitalization Treatment
(Full-day
Outpatient Care)
Suicidality
Weight as
percentage of
healthy body
weight
Generally
>85%
Generally
>80%
Generally >80%
Generally <85%
Motivation
to recover,
including cooperativeness,
insight, and
ability to control obsessive
thoughts
Fair-to-good
motivation
Fair
motivation
Partial
motivation;
cooperative;
patient
preoccupied
with intrusive,
repetitive
thoughts >3
hours/day
Poor-to-fair
motivation; patient
preoccupied with
intrusive repetitive
thoughts 46 hours
a day; patient
cooperative with
highly structured
treatment
Co-occurring
Presence of comorbid condition may influence choice of level of care
disorders
(substance use,
depression,
anxiety)
Structure
needed for
eating/gaining
weight
Selfsufficient
Needs supervision
during and after all
meals or nasogastric/
special feeding
modality
Ability to
control
compulsive
exercising
Can manage Some degree of external structure beyond self-control required to prevent
compulsive
patient from compulsive exercising; rarely a sole indication for increasing the
exercising
level of care
through selfcontrol
Selfsufficient
Needs some
structure to gain
weight
Needs supervision
at all meals or will
restrict eating
Page |28
Level One:
Outpatient
Level Two:
Intensive
Outpatient
Level Three:
Level Four:
Partial
Residential
Hospitalization Treatment
(Full-day
Outpatient Care)
Purging
behavior
(laxatives and
diuretics)
Environmental
stress
Geographic
availability
of treatment
program
Others able to
provide at least
limited support
and structure
Needs supervision
during and after
all meals and in
bathrooms; unable
to control multiple
daily episodes of
purging that are
severe, persistent,
and disabling, despite
trials of outpatient
care, even if routine
laboratory test results
reveal no obvious
abnormalities
Page |29
Page |30
Page |31
Selecting a psychotherapist
Just as not all psychotherapies are created equal, not
all therapists are created equally either. It matters
less how long a specific therapist has been practicing
and more on how skilled they are at treating eating
disorders and how up-to-date their knowledge is.
Although there may be exceptions, eating disorder
treatment generally addresses the following factors in
roughly this order:
1. Correct life-threatening medical and psychiatric
symptoms
2. Interrupt eating disorder behaviors (food
restriction, excessive exercise, binge eating,
purging, etc.)
3. Establish normalized eating and nutritional
rehabilitation
4. Challenge unhelpful and unhealthy eating disorder
and ED-related thoughts and behaviors
5. Address ongoing medical and mental health issues
6. Establish a plan to prevent relapse
Page |32
Page |33
Aripiprazole (Abilify)
Olanzapine (Zyprexa)
Quetiapine (Seroquel)
Risperidone (Risperdal)
Ziprasidone (Geodon)
Less frequently prescribed for eating disorder patients
Tricyclics
Amitriptyline (Elavil)
Clomipramine (Anafranil)
Citalopram (Celexa)
Escitalopram (Lexapro)
Fluvoxamine (Luvox)
Paroxetine (Paxil)
Sertraline (Zoloft)
Serotonin and Noradepinephrine Reuptake Inhibitor
Duloxetine (Cymbalta)
Venlafaxine (Effexor)
Desvenlafaxine (Pristiq)
Aminoketone
Alprazolam (Xanax)
Chlordiazepoxide (Librium)
Clonazepam (Klonopin)
Diazepam (Valium)
Lorazepam (Ativan)
Trazodone (Desyrel)
Monoamine Oxidase Inhibitors
Brofaromine (Consonar)
Isocarboxazide (Benazide)
Moclobemide (Manerix)
Phenelzine (Nardil)
Tranylcipromine (Parnate)
Tetracyclic Antidepressants
Mianserin (Bolvidon)
Mirtazapine (Remeron)
Mood Stabilizers (also used for anti-binge properties,
Page |34
Page |35
Can my loved one be admitted to treatment involuntarily? What are the criteria for making those
decisions? What steps would need to be taken?
Page |36
Page |37
Page |38
Page |39
Treatment Glossary
Antidepressants Prescription medications that
are FDA-approved for the treatment of major
depression, anxiety, or obsessive-compulsive
disorder. They are also used to treat eating disorders
with the goal of alleviating the depression and
anxiety that often coexist with an eating disorder.
Behavior Therapy (BT) A type of psychotherapy
that uses principles of learning to increase the
frequency of desired behaviors and/or decrease
the frequency of problem behaviors. Subtypes of
BT include dialectical behavior therapy (DBT) and
exposure and response prevention (EXRP).
Cognitive Therapy (CT) A type of
psychotherapeutic treatment that attempts to
change a patients feelings and behaviors by
changing the way the patient thinks about or
perceives his/her significant life experiences.
Subtypes include cognitive analytic therapy and
cognitive orientation therapy.
Cognitive Analytic Therapy (CAT) A type of
cognitive therapy that focuses its attention on
discovering how a patients problems have evolved
and how the procedures the patient has devised
to cope with them may be ineffective or even
harmful. CAT is designed to enable people to gain
an understanding of how the difficulties they
experience may be made worse by their habitual
coping mechanisms. Problems are understood in
the light of a persons personal history and life
experiences. The focus is on recognizing how these
coping procedures originated and how they can be
adapted.
Cognitive Behavior Therapy (CBT) CBT is a goaloriented, short-term treatment that addresses
the psychological, familial, and societal factors
associated with eating disorders. Therapy is
centered on the principle that there are both
behavioral and attitudinal disturbances regarding
eating, weight, and shape.
Cognitive Remediation Therapy (CRT) Since
patients with anorexia nervosa (AN) have a
tendency to get trapped in detail rather than seeing
the big picture, and have difficulty shifting thinking
among perspectives, this newly investigated brief
psychotherapeutic approach targets these specific
thinking styles and their role in the development
and maintenance of an eating disorder. Currently,
Page |40
Page |41
Page |42
Insurance Issues
Page |43
Educate yourself
Read the other information in the Parent Toolkit to
learn about eating disorders, treatment, current clinical
practice guidelines, and how you can best advocate
for and support the family member who has an eating
disorder. Refer to the latest evidence-based clinical
practice guidelines in this toolkit and have them in
hand when speaking to your health plan about benefits.
Be prepared to ask your health plan for the evidencebased information they use to create their coverage
policy for eating disorders.
Page |44
Document everything
Page |45
Page |46
Other steps:
1. Clinical Case Consultation Occasionally
reviewers need to consult with other clinicians
or doctors before determining how many days
they will authorize. This generally happens
after the patient has been in treatment for a
while, appears to meet the criteria for medical
necessity, but may be getting close to requiring
a doc-to-doc review. This is not a denial.
After consulting with either the clinical team
at the insurance company or with the treating
doctor at the facility/clinic, the reviewer will
call back with an authorization and usually a
few additional questions for the next review.
2. Doc-to-Doc or Peer-to-Peer Review
Cases are usually sent for a doc-to-doc for
one of the following reasons:
a) The patient has been in treatment for long
enough that the reviewer is unable to
authorize additional days without involving
a doctor from the insurance company.
b) The patient does not clearly meet the
criteria for medical necessity and a doctor
must use his or her clinical expertise/
discretion to determine if the level of care
being requested is warranted.
c) If this happens, it is fairly indicative of
an upcoming denial within the next few
reviews.
d) Although the insurance company may not
always honor the request, it is perfectly
acceptable (and recommended) to
specifically request for the reviewer to be a
doctor who specializes in eating disorders.
3. Appeal If authorization is denied, a facility/
provider has the right to file an appeal and
conduct a review with a different doctor.
Page |47
Page |48
b) Benefits
i. Does the member have benefits for the
services he or she is requesting?
ii. What is the copayment or coinsurance
for each type of service/level of care
(check whatever is relevant)
iii. Is there a limit? If so, how many
sessions have been used to date?
iv. Do the sessions cross-accumulate? (i.e.
Do OP or IOP days accumulate towards
total IP or PHP days allowed?)
Page |49
Page |50
Page |51
Page |52
Page |53
Page |54
Page |55
Page |56
Page |57
Page |58
In summary, [PATIENT NAME] intended to be a full-time student this fall until [his/her] treatment team suggested
otherwise in the early August. At that time I began notifying the insurance company. Please assist us in expediting
this process. I ask that you immediately reinstate [him/her] as a policy member. If [his/her] status is not resolved
immediately it will generate a GREAT DEAL of unnecessary extra work for all parties involved and, quite frankly, Im
not sure that our family can tolerate the useless labor when our energy is so depleted and needed for the medical/
life issues at hand.
I am attaching 1) my previous enrollment notification note; 2) [PATIENT NAMEs] acceptance from [UNIV. 2]; 3) a
copy of [PATIENT NAMES] apartment lease for the year; and 4) [his/her] recent letter to [UNIV. 2] notifying them
that [he/she] will be unable to complete the year as a visiting student for medical reasons. Please call me TODAY at
[PHONE #] to update me on this issue. This is very draining on our family. Thank you for your assistance.
Sincerely,
[YOUR NAME]
Cc: [CASE MANAGER, MENTAL HEALTH CLINICAL DIRECTOR, MEDICAL DIRECTOR]
Page |59
Page |60
Anorexia nervosa is a deadly disease with a 10% to 15% mortality rate; 15% to 25% of patients develop a severe
lifelong course. We believe that without intensive treatment in a residential program, [patient names and
condition], and the medical complications that it causes, will continue to worsen causing [him/her] to be at
significant risk of developing lifelong anorexia nervosa or dying of the disease. We understand that in the past,
your case reviewers have denied [patient] this level of care. This is the only appropriate and medically responsible
care plan that we can recommend. We truly believe that to offer a lesser level of care is medically negligent. We
trust that you will share our grave concern for [patients] medical needs and approve the recommended level of
care to assist in [his/her] recovery.
Thank you for your thorough consideration of this matter. Please feel free to contact us with any concerns
regarding [patients] care.
Sincerely,
[PHYSICIAN NAME]
Cc: [YOU]
Page |61
Page |62
Page |63
Making Sense of
Neuroscience
Page |64
Appetite
For people with eating disorders, the decision of what
to eat is a complicated snarl of anxiety and guilt. And
its not much less complicated for people without
eating disorders. Our appetitesfor what and how
much we eatare regulated by a complex array of
hormones, hunger, and desire. When these systems
are working properly, everything is great. We eat
what we need and want, more or less. Our weight is
appropriate for our genes and body type. Our diet is
varied and tasty.
As in any complex system, however, things can go
wrong. Research has shown us that eating disorder
sufferers have problems regulating feelings of hunger
and satiety that can perpetuate and perhaps even
contribute to the onset of illness. Scientists have
identified several key hormones and brain processes
that may be malfunctioning in people with eating
disorders. Leptin and ghrelin, discussed below, also
interact with a variety of other hunger and satiety
signals to help keep our bodies fueled properly.
Leptin is a hormone produced by fat cells that
signals satiety. Researchers at Rockefeller University
discovered the leptin gene almost 20 years ago (Zhang
et al., 1994), and researchers soon showed that leptin
is one of the (many) reasons why diets dont work. As
body fat stores go down, so do leptin levels. Lower
leptin levels mean that it takes longer to feel full after
eating, which serves to bring the body back to its
original weight.
Since leptin is a key component of appetite and body
weight regulation, scientists suspected that leptin
might be involved in eating disorders. Researchers
measured leptin levels in 67 women with eating
disorders (21 had anorexia, 32 had bulimia, and 14 had
binge eating disorder), and compared this to 25 healthy
women (Monteleone et al., 2000). As expected, leptin
levels were significantly elevated in the women with
binge eating disorder compared to healthy women, but
they were significantly lowered in women with anorexia
or bulimia.
Normally, high levels of leptin are associated with
lower levels of endocannabinoids, brain chemicals
that, among other things, regulate appetite (DiMarzo
et al., 2001). Low levels of endocannabinoids should
make a person feel less hungry. This isnt the case
in people with binge eating disorder; their elevated
leptin levels are actually associated with high levels of
Page |65
References
Cano, S. C., Merkestein, M., Skibicka, K. P., Dickson, S. L., &
Adan, R. A. (2012). Role of Ghrelin in the Pathophysiology
of Eating Disorders. CNS drugs, 26(4), 281-296. DOI:
10.2165/11599890-000000000-00000
Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Btkai, S., Jrai,
Z., ... & Kunos, G. (2001). Leptin-regulated endocannabinoids
are involved in maintaining food intake. Nature, 410(6830),
822-825. doi:10.1038/35071088
Frederich, R., Hu, S., Raymond, N., & Pomeroy, C. (2002).
Leptin in anorexia nervosa and bulimia nervosa: importance
of assay technique and method of interpretation. Journal of
Laboratory and Clinical Medicine, 139(2), 72-79. doi:10.1067/
mlc.2002.121014
Geliebter, A., Gluck, M. E., & Hashim, S. A. (2005). Plasma
ghrelin concentrations are lower in binge-eating disorder. The
Journal of Nutrition, 135(5), 1326-1330.
Jimerson, D. C., Mantzoros, C., Wolfe, B. E., & Metzger, E. D.
(2000). Decreased serum leptin in bulimia nervosa. Journal of
Clinical Endocrinology & Metabolism, 85(12), 4511-4514. doi:
10.1210/jc.85.12.4511
Page |66
Body Image
A common feature in many eating disorders is distorted
body image, and an overemphasis on the importance
of weight and shape to ones value as a person. Our
cultural emphasis on dieting, thin models, and digitally
altered images certainly plays a role. However, if
the body image distortions were only caused by
media factors, nearly everyone would suffer from an
eating disorder. Nor do cultural factors explain the
documented existence of eating disorders in cultures
and time periods without a cultural emphasis on
thinness. New research is showing that individuals
with eating disorders have differences in the way they
perceive their own shape and size that appears to be
strongly influenced by biology.
Everyone has a body image. Researchers define body
image as the way we picture and perceive our bodies
in our minds, and this perception is shaped by broader
cultural factors, our own individual experiences, and
by how our brains perceive the size of our bodies and
how they move through space. Only in more recent
years have scientists begun to tease apart how these
neurological factors can affect the development of
body image in eating disorders.
It appears that several regions of the brain are involved
in this body image distortion. In a neuroimaging study
of women recovered from binge/purge anorexia,
researchers found that higher serotonin receptor
activity in the left parietal cortex was associated
with lower drive for thinness (Bailer et al., 2004). A
separate study also found abnormal activation of the
parietal cortex when individuals with anorexia were
asked to look at pictures of themselves (Wagner et al.,
2003). The parietal cortex helps to create a map of the
body using the sensory information it processes, and
researchers have hypothesized that problems with
creating this body map may at least in part underlie
body image distortions in eating disorders (Titova et
al., 2013). This hypothesis is supported by research
that showed patients currently ill with anorexia had
problems retrieving accurate information about their
body shape that caused them to overestimate their
current body size (Mohr et al., 2010).
These distortions also appear to involve the brains fear
circuitry. Scientists in Germany asked three adolescents
currently hospitalized for anorexia to view pictures
of their own body that had been digitally altered to
appear larger and thus simulate the teens actual body
image. When the teens with anorexia looked at the
Page |67
References (continued)
Mohr, H. M., Zimmermann, J., Rder, C., Lenz, C., Overbeck,
G., & Grabhorn, R. (2010). Separating two components of
body image in anorexia nervosa using fMRI. Psychological
Medicine, 40(9), 1519. DOI: 10.1017/S0033291709991826
Mussell, M. P., Peterson, C. B., Weller, C. L., Crosby, R. D.,
Zwaan, M., & Mitchell, J. E. (1996). Differences in body image
and depression among obese women with and without
binge eating disorder. Obesity Research, 4(5), 431-439. DOI:
10.1002/j.1550-8528.1996.tb00251.x
Seeger, G., Braus, D. F., Ruf, M., Goldberger, U., & Schmidt, M.
H. (2002). Body image distortion reveals amygdala activation
in patients with anorexia nervosaa functional magnetic
resonance imaging study. Neuroscience Letters, 326(1), 25-28.
DOI: 10.1016/S0304-3940(02)00312-9
Suisman, J. L., OConnor, S. M., Sperry, S., Thompson, J.
K., Keel, P. K., Burt, S. A., ... & Klump, K. L. (2012). Genetic
and environmental influences on thinideal internalization.
International Journal of Eating Disorders, 45(8), 942-948. DOI:
10.1002/eat.22056
Titova, O. E., Hjorth, O. C., Schith, H. B., & Brooks, S. J.
(2013). Anorexia nervosa is linked to reduced brain structure
in reward and somatosensory regions: a meta-analysis of
VBM studies. BMC psychiatry, 13(1), 110. doi:10.1186/1471244X-13-110
Vocks, S., Busch, M., Grnemeyer, D., Schulte, D., Herpertz, S.,
& Suchan, B. (2010). Neural correlates of viewing photographs
of ones own body and another womans body in anorexia
and bulimia nervosa: an fMRI study. Journal of psychiatry &
neuroscience: JPN, 35(3), 163. doi: 10.1503/jpn.090048
Wade, T. D., & Tiggemann, M. (2013). The role of
perfectionism in body dissatisfaction. J Eat Disord, 1(2).
doi:10.1186/2050-2974-1-2
Wagner, A., Ruf, M., Braus, D. F., & Schmidt, M. H. (2003).
Neuronal activity changes and body image distortion in
anorexia nervosa. Neuroreport, 14(17), 2193-2197.
Page |68
Neurotransmitters
Although eating disorders result from the interplay of
a variety of cultural and biological factors, the brain
is central to understanding why some people develop
eating disorders, why people stay ill, and how they
can recover. In recent years, scientists have made
tremendous strides in understanding the brain science
of eating disorders.
Based on evidence from hundreds of studies, it
appears that one of the factors that make a person
more likely to develop an eating disorder is how their
brain functions. Researchers have identified specific
neurobiological differences in the brains of people
with anorexia, bulimia, or binge eating disorder. These
differences affect how we eat, as well as things like
mood, anxiety, personality, and decision-making.
This section will introduce you to the basics of eating
disorder neurobiology, and how various neural systems
work together in individuals with eating disorders.
Neurons
Neurons send signals to each other using chemicals
known as neurotransmitters. The type and amount
of neurotransmitters released will tell neighboring
neurons whether to become active or to stay silent.
The body produces an array of neurotransmitters and
their receptors, which are proteins on the surface of the
cell that recognize a specific neurotransmitter and relay
the signal from the outside to the inside of the cell. Small
variations in the shape and number of receptors, as well
as the amount of neurotransmitter producedknown
as polymorphismsexist in the population, which
increase or decrease the amount of neurotransmitter in
the synapse (the small space between a neuron and its
neighbors) and our sensitivity to it. These variations have
been linked to a variety of mental illnesses, including
eating disorders.
For eating disorders, there are two primary neurotransmitters you need to know about: serotonin and dopamine. Each of these neurotransmitters has an influence
in how we think and behave, our personalities, and even
perhaps our risk for developing an eating disorder.
Serotonin
Given that serotonin (sometimes referred to as
5-hydroxytryptophan) helps control everything from
memory and learning to sleep, mood, and appetite,
Page |69
Dopamine
Dopamine is commonly thought of as the pleasure
chemical, due to its links with rewarding behaviors
and drugs of abuse. Although dopamine is involved in
reward-motivated behavior (such as studying to get
good grades, or going to work early to get a raise), it
also helps regulate movement, memory, hormones
and pregnancy, and sensory processing (Beaulieu &
Gainetdinov, 2011). Like serotonin, the overlap of
processes controlled by dopamine and eating disorderrelated symptoms caused researchers to investigate
potential associations.
In anorexia, the leading hypothesis is that the disorder
is associated with an over-production of dopamine,
leading to anxiety (Bailer et al., 2012a), harm avoidance
(Bailer et al., 2012b), hyperactivity and the ability to go
without pleasurable things like food (Kontis & Theochari,
2012). Research has shown that bulimia is associated
with lower levels of both dopamine and certain of
its receptors, and that binge eating is significantly
associated with dopamine release in certain parts of
the brain (Broft et al., 2012). Binge eating disorder
has been linked to a hyper-responsiveness to rewards
such as food, which makes eating more rewarding and
pleasurable than in people without this disorder (Davis
et al., 2012) and leads to a continuation of compulsive
overeating (Bello & Hajnal, 2010).
References
Akkermann, K., Nordquist, N., Oreland, L., & Harro, J. (2010).
Serotonin transporter gene promoter polymorphism affects
the severity of binge eating in general population. Progress in
Neuro-Psychopharmacology and Biological Psychiatry, 34(1),
111-114. doi: 10.1016/j.pnpbp.2009.10.008
Bailer, U. F., Narendran, R., Frankle, W. G., Himes, M. L.,
Duvvuri, V., Mathis, C. A., & Kaye, W. H. (2012). Amphetamine
induced dopamine release increases anxiety in individuals
recovered from anorexia nervosa. International Journal of
Eating Disorders, 45(2), 263-271. DOI: 10.1002/eat.20937
Bailer, U. F., Frank, G. K., Price, J. C., Meltzer, C. C., Becker, C.,
Mathis, C. A., ... & Kaye, W. H. (2012b). Interaction between
serotonin transporter and dopamine D2/D3 receptor
radioligand measures is associated with harm avoidant
symptoms in anorexia and bulimia nervosa. Psychiatry Research:
Neuroimaging. doi:10.1016/j.pscychresns.2012.06.010
Bello, N. T., & Hajnal, A. (2010). Dopamine and binge eating
behaviors. Pharmacology Biochemistry and behavior, 97(1),
25-33. doi: 10.1016/j.pbb.2010.04.016
Beaulieu, J. M., & Gainetdinov, R. R. (2011). The physiology,
signaling, and pharmacology of dopamine receptors.
Pharmacological reviews, 63(1), 182-217. doi: 10.1124/
pr.110.002642
Broft, A., Shingleton, R., Kaufman, J., Liu, F., Kumar, D.,
Slifstein, M., ... & Walsh, B. T. (2012). Striatal dopamine in
bulimia nervosa: A pet imaging study. International Journal of
Eating Disorders, 45(5), 648-656. DOI: 10.1002/eat.20984
Bruce, K. R., Steiger, H., Joober, R., Kin, N. M. K., Israel,
M., & Young, S. N. (2005). Association of the promoter
polymorphism 1438G/A of the 5HT2A receptor gene with
behavioral impulsiveness and serotonin function in women
with bulimia nervosa. American Journal of Medical Genetics
Part B: Neuropsychiatric Genetics, 137(1), 40-44.
Davis, C., Levitan, R. D., Yilmaz, Z., Kaplan, A. S., Carter, J. C., &
Kennedy, J. L. (2012). Binge eating disorder and the dopamine
D2 receptor: Genotypes and sub-phenotypes. Progress in
Neuro-Psychopharmacology and Biological Psychiatry, 38(2),
328-335. doi: 10.1016/j.pnpbp.2012.05.002
Kontis, D., & Theochari, E. (2012). Dopamine in anorexia
nervosa: a systematic review. Behavioural Pharmacology, 23(5
and 6), 496-515. doi: 10.1097/FBP.0b013e328357e115
Haedt-Matt, A. A., & Keel, P. K. (2011). Revisiting the affect
regulation model of binge eating: A meta-analysis of studies
using ecological momentary assessment. Psychological
bulletin, 137(4), 660. doi: 10.1037/a0023660
Page |70
References (continued)
Kaye, W. H., Gwirtsman, H. E., George, D. T., & Ebert, M. H.
(1991). Altered serotonin activity in anorexia nervosa after
long-term weight restoration: does elevated cerebrospinal
fluid 5-hydroxyindoleacetic acid level correlate with rigid and
obsessive behavior? Archives of General Psychiatry, 48(6), 556.
doi: 10.1001/archpsyc.1991.01810300068010
Kaye, W. H., Frank, G. K., Meltzer, C. C., Price, J. C., McConaha,
C. W., Crossan, P. J., ... & Rhodes, L. (2001). Altered serotonin
2A receptor activity in women who have recovered from
bulimia nervosa. American Journal of Psychiatry, 158(7), 11521155. doi:10.1176/appi.ajp.158.7.1152
Kaye, W. H., Fudge, J. L., & Paulus, M. (2009). New insights
into symptoms and neurocircuit function of anorexia nervosa.
Nature Reviews Neuroscience, 10(8), 573-584. doi:10.1038/
nrn2682
Gorwood, P., Ades, J., Bellodi, L., Cellini, E., Collier, D. A.,
Di Bella, D., ... & Treasure, J. (2002). The 5-HT2A-1438G/A
polymorphism in anorexia nervosa: A combined analysis of
316 trios from six European centres. Molecular psychiatry,
7(1), 90-94. doi: 10.1038/sj/mp/4000938
Racine, S. E., Culbert, K. M., Larson, C. L., & Klump, K. L.
(2009). The possible influence of impulsivity and dietary
restraint on associations between serotonin genes and binge
eating. Journal of psychiatric research, 43(16), 1278-1286. doi:
10.1016/j.jpsychires.2009.05.002
Steiger, H., Young, S. N., Ng Ying Kin, N. M. K., Koerner,
N., Israel, M., Lageix, P., & Paris, J. (2001). Implications of
impulsive and affective symptoms for serotonin function in
bulimia nervosa. Psychological Medicine, 31(01), 85-95.
Page |71
Reward
In eating disorders, scientists have identified problems
not only with the physical sensations of hunger and
fullness, but also with how rewarding food is. If an
animal doesnt eat enough, it will die, so necessities
like eating are generally quite pleasurable to ensure
that we stay alive. This pleasure helps reinforce the
behaviors, thoughts, and memories that lead to
eating. Alternately, the brain usually perceives hunger
as being uncomfortable to motivate us to go eat
something. Research has shown us that the brains
reward pathways are altered in individuals with eating
disorders, making them more or less able to perceive
and respond to pleasurable things.
Normally, when we are hungry, food is more rewarding
than when we are full (Bragulat et al., 2010), as
evidenced by the increased release of dopamine in the
nucleus accumbens, which is known to play a role in
pleasure, reward, addiction and fear (Avena, Rada, &
Hoebel, 2008). Given that food restriction frequently
accompanies binge eating behavior (Stice et al., 2000),
the binge becomes even more rewarding in these
individuals than the normal satiation of hunger. The
post-binge guilt leads to further food restriction, which
serves to maintain the high reward of binge eating
(Carr, 2011).
Neuroimaging studies in women with bulimia revealed
that their brains reward pathways are significantly
more active than in healthy controls when they viewed
pictures of food (Brooks et al., 2011). Women with the
binge/purge type of anorexia also showed significantly
higher reward sensitivity (Harrison et al., 2010).
Despite increased awareness and diagnosis of binge
eating in males, the disorder is still significantly more
common in females. Some researchers believe that
female sex hormones may help increase reward
sensitivity (Klump et al., 2013). Scientists are currently
testing this idea.
In bulimia, purging appears to be rewarding as well.
One study found a significant association between
higher reward sensitivity and frequency of purging in
women with bulimia (Farmer, Nash, & Field, 2001). One
potential explanation for this is that purging decreases
the amount of acetylcholine in the brain, high levels
of which have been found to be unpleasant (Avena &
Bocarsly, 2012).
Page |72
Page |73
Anorexia Nervosa
People who suffer from anorexia nervosa tend to
have high levels of harm avoidance, a personality trait
characterized by worrying, pessimism, and shyness, and
low levels of novelty seeking, which includes impulsivity
and preferring new or novel things (Fassino et al.,
2002). The different subtypes of anorexia have slightly
different personality traits, with the binge/purge
subtype showing slightly higher levels of impulsivity
and novelty-seeking (Bulik et al., 1995). The restricting
subtype had higher levels of persistence (Klump et al.,
2000). Researchers have linked higher levels of harm
avoidance with higher levels of serotonin in the brain
(Cloninger, 1985), and scientists have linked harm
avoidance with specific alterations in the serotonin
system in women recovered from anorexia (Bailer et
al., 2005).
A study measuring slightly different facets of personality
found that women with either the restricting or
binge/purge subtype of anorexia had higher levels of
neuroticism (characterized by depression, anxiety,
worry, and moodiness) than controls, and that women
with restricting anorexia scored higher on measures of
agreeableness and conscientiousness than those with
the binge/purge type (Bollen & Wojciechowski, 2004).
Bulimia Nervosa
Individuals with bulimia nervosa have high levels of
harm avoidance like anorexia sufferers, but instead its
paired with high levels of novelty seeking (Fassino et
al., 2002). This study found that those with the binge/
purge subtype of anorexia show traits that are midway
between restricting anorexia and bulimia. Other
research has found high levels of impulsivity, emotion
Page |74
References:
Anderluh, M. B., Tchanturia, K., Rabe-Hesketh, S., & Treasure,
J. (2003). Childhood obsessive-compulsive personality traits in
adult women with eating disorders: defining a broader eating
disorder phenotype. American Journal of Psychiatry, 160(2),
242-247. doi:10.1176/appi.ajp.160.2.242
Groleau, P., Steiger, H., Joober, R., Bruce, K. R., Israel, M.,
Badawi, G., ... & Sycz, L. (2012). Dopamine-system genes,
childhood abuse, and clinical manifestations in women with
Bulimia-spectrum Disorders. Journal of psychiatric research,
46(9), 1139-1145. doi: 10.1016/j.jpsychires.2012.05.018
Bailer, U. F., Frank, G. K., Henry, S. E., Price, J. C., Meltzer, C. C.,
Weissfeld, L., ... & Kaye, W. H. (2005). Altered brain serotonin
5-HT1A receptor binding after recovery from anorexia
nervosa measured by positron emission tomography and
[carbonyl11C] WAY-100635. Archives of general psychiatry,
62(9), 1032. doi:10.1001/archpsyc.62.9.1032.
Page |75
NEDA Headquarters
165 West 46th Street, Suite 402
New York, NY 10036
212-575-6200
Toll-free Information and
Referral Helpline: 800-931-2237
Helpline hours are
9:00am to 9:00pm Monday to Thursday (Eastern Time)
9:00am to 5:00pm Friday (Eastern Time)
Website: www.NationalEatingDisorders.org